Product Information
RALOXIFENE HCL 60 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2359 per EA under NDC 00093729056. Its NADAC has been published 636 times since Jun 18, 2014.
FDA first approved this application on Mar 4, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
60 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093729056
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RALOXIFENE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078193FDA Approved
3/4/2014
TE Code
AB
On Market Since
3/28/2014
Pharmacological Classes
Price Statistics
The NADAC for RALOXIFENE HCL 60 MG TABLET has been published 636 times since Jun 18, 2014, and over the history we have for it it has declined 95.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2359 per EA |
|---|---|
| All-time high | $5.1547 (Jul 16, 2014) |
| All-time low | $0.2054 (Nov 20, 2024) |
| 52-week high | $0.2609 |
| 52-week low | $0.2359 |
| Median price | $0.4936 |
| Average price | $1.0710 |
| Largest weekly change | +31.5% (Jan 22, 2020) |
| Weeks tracked | 636 |
| Tracking since | Jun 18, 2014 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RALOXIFENE HCL 60 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RALOXIFENE HCL 60 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.2359 per EA (NDC 00093729056), effective Aug 19, 2026.
How has the price of RALOXIFENE HCL 60 MG TABLET changed over time?
Over the history we have for it, the NADAC for RALOXIFENE HCL 60 MG TABLET has declined 95.4%. It has been tracked across 636 weekly CMS publications since Jun 18, 2014.
What are the highest and lowest recorded NADAC prices for RALOXIFENE HCL 60 MG TABLET?
Since Jun 18, 2014, the NADAC for RALOXIFENE HCL 60 MG TABLET has ranged from a low of $0.2054 (Nov 20, 2024) to a high of $5.1547 (Jul 16, 2014), with a median of $0.4936 per EA.
Are there cheaper alternatives to RALOXIFENE HCL 60 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RALOXIFENE HCL 60 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures RALOXIFENE HCL 60 MG TABLET?
RALOXIFENE HCL 60 MG TABLET (NDC 00093729056) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.